Low testosterone levels may indicate worsening of disease for men with prostate cancer

May 5, 2014, Wiley
Micrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia

For men with low-risk prostate cancer, low levels of testosterone may indicate a worsening of their disease. That's the conclusion of a new study published in BJU International. The findings may help physicians identify patients with low-risk prostate cancer who should receive aggressive anticancer treatment.

Men with prostate cancer that is not life threatening and is only slowly progressing, can often forego treatment and instead undergo active surveillance. This involves close monitoring to ensure that their disease does not become serious and jeopardize their health. Unfortunately, doctors currently have no reliable way of predicting which men will develop evidence of worsening or more aggressive disease during active surveillance.

Ignacio San Francisco, MD, of the Pontificia Universidad Católica de Chile, and his colleagues looked to see if levels might provide any indication. After following 154 men with low-risk prostate cancer for 38 months, the investigators found that low levels of free testosterone were significantly linked with an increased risk of developing more aggressive disease. They found no significant association with total testosterone concentrations, although there was a general trend towards increased risk with lower levels. Free testosterone comprises one to two percent of total testosterone and is considered a useful surrogate for the biologically active portion of circulating testosterone.

"These results suggest low levels of testosterone are associated with more aggressive prostate cancer. This contradicts long-held beliefs that high testosterone is risky for prostate cancer, and low testosterone is protective," said Dr. San Francisco.

The results of this study provide valuable information to clinicians and their patients concerning risk factors for progression in men undergoing . "In borderline cases, the presence of low values of free testosterone may help determine whether it is more prudent to initiate treatment rather than continue observation," said Dr. San Francisco.

Explore further: Men, women in more satisfying relationships have lower testosterone

More information: "Low free testosterone predicts disease reclassification in men with prostate cancer undergoing active surveillance." Ignacio F. San Francisco, Pablo A. Rojas, William C. DeWolf, Abraham Morgentaler. BJU International; Published Online: May 5, 2014. DOI: 10.1111/bju.12682

Related Stories

Men, women in more satisfying relationships have lower testosterone

April 11, 2014
(Medical Xpress)—Many people assume that the more testosterone, the better, but a new University of Michigan study finds that might not always be the case in romantic relationships.

Study suggests another look at testosterone-prostate cancer link

April 19, 2011
The long-standing prohibition against testosterone therapy in men with untreated or low-risk prostate cancer merits reevaluation, according to a new study published in The Journal of Urology.

More testosterone increases prostate cancer risk in older men: study

July 26, 2012
(Medical Xpress) -- Older men - those in their 70s and 80s - with higher levels of testosterone, including those who undergo hormone replacement therapy, are at an increased risk of prostate cancer, according to new research.  

Male health linked to testosterone exposure in womb, study finds

April 22, 2014
Men's susceptibility to serious health conditions may be influenced by low exposure to testosterone in the womb, new research suggests.

Drop in testosterone tied to prostate cancer recurrence

October 28, 2012
Men whose testosterone drops following radiation therapy for prostate cancer are more likely to experience a change in PSA levels that signals their cancer has returned, according to new research from Fox Chase Cancer Center. ...

Large clinical trials to evaluate risks of testosterone treatment urgently needed

April 28, 2014
Physicians do not have sufficient information from clinical trials to understand the risks associated with the prescription of testosterone in older men, according to a Comment in The Lancet Diabetes & Endocrinology, written ...

Recommended for you

New approach attacks 'undruggable' cancers from the outside in

January 23, 2018
Cancer researchers have made great strides in developing targeted therapies that treat the specific genetic mutations underlying a patient's cancer. However, many of the most common cancer-causing genes are so central to ...

Study: Cells of three advanced cancers die with drug-like compounds that reverse chemo failure

January 23, 2018
Researchers at Southern Methodist University have discovered three drug-like compounds that successfully reverse chemotherapy failure in three of the most commonly aggressive cancers—ovarian, prostate and breast.

'Hijacker' drives cancer in some patients with high-risk neuroblastoma

January 23, 2018
Researchers have identified mechanisms that drive about 10 percent of high-risk neuroblastoma cases and have used a new approach to show how the cancer genome "hijacks" DNA that regulates other genes. The resulting insights ...

Enzyme inhibitor combined with chemotherapy delays glioblastoma growth

January 23, 2018
In animal experiments, a human-derived glioblastoma significantly regressed when treated with the combination of an experimental enzyme inhibitor and the standard glioblastoma chemotherapy drug, temozolomide.

Researchers identify a protein that keeps metastatic breast cancer cells dormant

January 23, 2018
A study headed by ICREA researcher Roger Gomis at the Institute for Research in Biomedicine (IRB Barcelona) has identified the genes involved in the latent asymptomatic state of breast cancer metastases. The work sheds light ...

Boosting cancer therapy with cross-dressed immune cells

January 22, 2018
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

Anti Aging Doctor Tampa
not rated yet May 05, 2014
This is such a great article and I am so glad you are trying to share it with the public to increase common knowledge on such a serious condition. We believe truly believe in these results and have compiled information on a webpage to try boost general knowledge on the subject. You can see our findings at http://www.ageman...one.html .

For those of you wondering whether you may have low testosterone levels, see the symptoms at http://www.ageman...symptoms .

Let us know what you think!

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.